Methods of treating immune disorders with single domain antibodies against TNF-alpha

The invention relates to the TNFX binding molecule ozoralizumab (ATN-103), methods of using this molecule to treat immune disorders, including rheumatoid arthritis, and specific dosing regimens for the treatment of rheumatoid arthritis. 本发明涉及结合TNFX的分子ozoralizumab(ATN-103)，使用该分子治疗免疫病症的方法，所述免疫病症包括类风湿性...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHARMA AMARNATH, COMER GAIL, HEGEN MARTIN, SHIELDS KATHY
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the TNFX binding molecule ozoralizumab (ATN-103), methods of using this molecule to treat immune disorders, including rheumatoid arthritis, and specific dosing regimens for the treatment of rheumatoid arthritis. 本发明涉及结合TNFX的分子ozoralizumab(ATN-103)，使用该分子治疗免疫病症的方法，所述免疫病症包括类风湿性关节炎，和用于治疗类风湿性关节炎的具体的给药方案。